Cargando…
(18)F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
BACKGROUND: The methylation status of the O(6)-methylguanine-DNA methyltransferase (MGMT) promoter has emerged as a favorable independent prognostic and predictive biomarker in glioma. This study aimed to build a radiomics signature based on (18)F-fluorodeoxyglucose (FDG) positron emission tomograph...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701097/ https://www.ncbi.nlm.nih.gov/pubmed/31426864 http://dx.doi.org/10.1186/s40644-019-0246-0 |